Informed Consent: BISA Submits Comments On FDA Draft Guidance
BISA submitted public comments on the FDA’s recent draft guidance on improving the informed consent process.
BISA Responds to Statements on Explant Recommendation For Textured Breast Implants
BISA delves into the agency statements on the recently published recommendations about the removal of textured implants in asymptomatic patients.
Public Health Coalition Says US FDA Center Directors Should Not Influence Adcomm Votes Or Overrule Scientific Staff
BISA is part of the Patient, Consumer and Public Health Coalition. The Coalition recently sent a letter to the FDA’s Commissioner Robert Califf expressing concerns about Advisory Committees.
New Podcast released from “Two Women and a Mic” about Breast Implants, the FDA, Informed Consent and More with Maria Gmitro
Maria Gmitro of Breast Implant Safety Alliance (BISA) addresses breast implant related illness and cancers, BIA-ALCL, and BIA-SCC with a focus on informed consent and her personal experience with breast implants, advocacy and the FDA.